Gilead Sciences, Inc. (GILD) is listed on NASDAQ in Biotech Stocks. It is $145.64, -2.16%, with a $180.6B market cap. RSI is 60.3, near overbought. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 60.3 Near Overbought
Market Cap $180.6B
Volume 2.9M
Fundamentals — 10-Q Q2 2026
Revenue $14.8B
Net Income $-8.5B
EPS $-6.82
Gross Margin 79.5%
Operating Margin -52.9%
Net Margin -57.4%
Debt / Equity 2.2x
P/E Ratio -21.4x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Welters Anthony | Director | Sell | 18,000 | $148.62 | $2.7M | 2026 Aug 26 |
| Bluestone Jeffrey | Director | Sell | 5,000 | $145.02 | $725,078 | 2026 Aug 20 |
| Dickinson Andrew D | Chief Financial Officer | Sell | 3,000 | $138.36 | $415,080 | 2026 Aug 17 |
| Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 28,000 | $137.64 | $3.9M | 2026 Aug 17 |
| O'day Daniel Patrick | Chairman & CEO | Sell | 15,000 | $130.31 | $2.0M | 2026 Aug 3 |
| Dickinson Andrew D | Chief Financial Officer | Sell | 3,000 | $129.93 | $389,777 | 2026 Jul 15 |
| Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 3,000 | $129.92 | $389,758 | 2026 Jul 15 |
| O'day Daniel Patrick | Chairman & CEO | Sell | 15,000 | $126.29 | $1.9M | 2026 Jul 1 |
| Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 3,000 | $123.92 | $371,762 | 2026 Jun 15 |
| Dickinson Andrew D | Chief Financial Officer | Sell | 3,000 | $125.40 | $376,200 | 2026 Jun 15 |
| O'day Daniel Patrick | Chairman & CEO | Sell | 15,000 | $131.46 | $2.0M | 2026 Jun 1 |
| Dickinson Andrew D | Chief Financial Officer | Sell | 3,000 | $132.27 | $396,810 | 2026 May 15 |
| Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 28,000 | $131.29 | $3.7M | 2026 May 15 |
| O'day Daniel Patrick | Chairman & CEO | Sell | 10,000 | $129.16 | $1.3M | 2026 Apr 28 |
| Dickinson Andrew D | Chief Financial Officer | Sell | 3,000 | $140.96 | $422,880 | 2026 Apr 15 |
| Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 3,000 | $140.96 | $422,880 | 2026 Apr 15 |
| O'day Daniel Patrick | Chairman & CEO | Sell | 10,000 | $136.82 | $1.4M | 2026 Mar 27 |
| Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 3,000 | $144.23 | $432,690 | 2026 Mar 16 |
| Dickinson Andrew D | Chief Financial Officer | Sell | 3,000 | $144.23 | $432,690 | 2026 Mar 16 |
| O'Day Daniel Patrick | Chairman & CEO | Sell | 10,000 | $144.79 | $1.4M | 2026 Feb 27 |
Other Biotech Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $137.93 | 63.6 | $55.1B |
| | $432.33 | 66.2 | $233.7B |
| | $208.02 | 55.9 | $44.6B |
| | $1,023.96 | 63.8 | -- |
| | $141.42 | 61.5 | $8.9B |
| | $102.12 | 51.7 | -- |
| | $134.97 | 69.6 | $10.2B |
| | $105.31 | 69.1 | $12.0B |
Take GILD further
- Browse Biotech Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put GILD in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Gilead Sciences, Inc. next reports.
Set alerts on GILD
Get notified when Gilead Sciences, Inc. hits your price targets or technical conditions are met.
Get Started Free